This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| FDA | 1393 |
| Case | 730 |
| RBC | 579 |
| Study | 573 |
| Design | 530 |
| US | 517 |
| Studies | 493 |
| Background | 483 |
| SARS | 477 |
| States | 423 |
| ICH | 388 |
| CT | 388 |
| COVID-19 | 359 |
| MRI | 355 |
| CoV-2 | 328 |
| Drug | 318 |
| United | 307 |
| Health | 303 |
| Blood | 300 |
| HIV | 293 |
| RNA | 289 |
| Report | 274 |
| EU | 262 |
| PCR | 258 |
| University | 243 |
| Purpose | 241 |
| C | 239 |
| A | 235 |
| HCV | 228 |
| Food | 224 |
| Committee | 224 |
| Administration | 216 |
| Center | 208 |
| EMA | 204 |
| Hospital | 199 |
| ABO | 186 |
| MR | 186 |
| Medical | 184 |
| B | 178 |
| European | 175 |
| WHO | 174 |
| Methods | 169 |
| Member | 169 |
| RHD | 168 |
| MD | 168 |
| PLT | 165 |
| National | 165 |
| Act | 160 |
| Children | 160 |
| American | 156 |
| ▸ | 154 |
| • | 154 |
| T | 148 |
| Rh | 148 |
| II | 148 |
| NAT | 140 |
| Radiology | 139 |
| U.S. | 135 |
| D | 135 |
| HLA | 134 |
| Pediatric | 132 |
| Ebola | 128 |
| M | 123 |
| Human | 121 |
| Europe | 121 |
| Transfusion | 119 |
| mg | 118 |
| S | 118 |
| TPE | 115 |
| HBV | 113 |
| Group | 113 |
| RT | 112 |
| Medicine | 111 |
| Dr. | 111 |
| CDC | 108 |
| Disease | 105 |
| System | 104 |
| Steering | 102 |
| Institute | 101 |
| International | 100 |
| RdRp | 98 |
| Clinical | 97 |
| Department | 96 |
| WBC | 96 |
| ZIKV | 95 |
| Research | 95 |
| CoV | 95 |
| New | 94 |
| Hb | 93 |
| Society | 92 |
| Zika | 91 |
| China | 91 |
| Anti | 91 |
| Use | 90 |
| DNA | 88 |
| Services | 88 |
| January | 87 |
| Safety | 85 |
| AP | 84 |
| M. | 83 |
| Review | 81 |
| Phase | 81 |
| Control | 81 |
| ASEAN | 81 |
| PR | 80 |
| EC | 79 |
| DTC | 78 |
| K | 78 |
| L | 78 |
| WB | 78 |
| Laboratory | 77 |
| Evaluation | 77 |
| Medicines | 75 |
| DTT | 75 |
| C. | 75 |
| March | 74 |
| R | 73 |
| April | 72 |
| Agency | 72 |
| MTP | 71 |
| B. | 71 |
| Patient | 71 |
| Quality | 71 |
| USA | 70 |
| Table | 69 |
| SADC | 69 |
| Management | 69 |
| CD36 | 69 |
| July | 68 |
| GI | 68 |
| CMV | 68 |
| Imaging | 67 |
| State | 66 |
| Donor | 66 |
| Coronavirus | 66 |
| TM | 66 |
| Japan | 66 |
| Red | 66 |
| World | 65 |
| MS | 65 |
| HIV-1 | 65 |
| DAT | 65 |
| College | 64 |
| < | 64 |
| Office | 64 |
| FFP | 64 |
| ID | 64 |
| Regulatory | 63 |
| IPC | 63 |
| GMP | 63 |
| Association | 63 |
| Service | 62 |
| NIH | 62 |
| G | 62 |
| Council | 62 |
| Community | 61 |
| AIDS | 61 |
| CASI | 61 |
| Working | 61 |
| S. | 61 |
| T2 | 61 |
| September | 60 |
| November | 60 |
| IV | 60 |
| December | 60 |
| APEC | 59 |
| SCD | 59 |
| Virus | 59 |
| Organization | 58 |
| HLD | 58 |
| E | 58 |
| Products | 58 |
| J | 57 |
| Immucor | 57 |
| CSF | 56 |
| IND | 55 |
| ATP | 55 |
| Emergency | 54 |
| June | 54 |
| Inc. | 54 |
| RHCE | 53 |
| GCC | 53 |
| Federal | 53 |
| Development | 53 |
| Bank | 53 |
| AABB | 53 |
| Diagnostics | 52 |
| CI | 52 |
| MERS | 52 |
| IgG | 52 |
| Tg | 52 |
| H1N1 | 51 |
| February | 51 |
| Guidance | 51 |
| Vaccine | 50 |
| Directive | 50 |
| Centers | 50 |
| I | 49 |
| BC | 49 |
| Materials | 49 |
| Treatment | 48 |
| Public | 48 |
| Program | 48 |
| NGS | 48 |
| May | 48 |
| EUA | 48 |
| America | 48 |
| anti | 48 |
| E. | 47 |
| D. | 47 |
| RSV | 47 |
| Syndrome | 47 |
| TTP | 46 |
| SPR | 46 |
| IgM | 46 |
| CTD | 46 |
| Cross | 45 |
| Animal | 45 |
| Assessment | 45 |
| August | 45 |
| Commission | 45 |
| Molecular | 45 |
| October | 45 |
| Union | 45 |
| kcal | 45 |
| P. | 44 |
| Network | 44 |
| IVIG | 44 |
| IRB | 44 |
| Guideline | 44 |
| HPC | 43 |
| ACE2 | 43 |
| Cell | 43 |
| HOD | 43 |
| IR | 43 |
| Procedure | 43 |
| TS | 43 |
| West | 43 |
| Prevention | 42 |
| J. | 42 |
| IH | 42 |
| EMR | 42 |
| BP | 42 |
| CBER | 41 |
| Board | 41 |
| ED | 41 |
| mAbs | 40 |
| U | 40 |
| Testing | 40 |
| Pharmaceutical | 40 |
| L. | 40 |
| III | 40 |
| Healthcare | 40 |
| Fig | 40 |
| EBOV | 40 |
| Hgb | 39 |
| Advisory | 39 |
| IAT | 39 |
| PANDRH | 39 |
| Ortho | 39 |
| India | 39 |
| Practice | 38 |
| Marrow | 38 |
| Luminex | 38 |
| KEL | 38 |
| HSR | 38 |
| Cancer | 38 |
| CLIA | 38 |
| GCG | 37 |
| Canada | 37 |
| Day | 37 |
| East | 37 |
| F | 37 |
| Mycobacterium | 37 |
| HTLV | 37 |
| IU | 37 |
| PD | 37 |
| PET | 37 |
| Congress | 36 |
| PEG | 36 |
| Africa | 36 |
| Jk | 36 |
| Plasma | 36 |
| sha | 36 |
| cGMP | 36 |
| Washington | 36 |
| dl | 35 |
| WNV | 35 |
| Vaccines | 35 |
| MSC | 35 |
| Infectious | 35 |
| DWI | 35 |
| CFR | 35 |
| Ab | 35 |
| Information | 34 |
| CNS | 34 |
| California | 34 |
| George | 34 |
| IL-6 | 34 |
| Apheresis | 34 |
| MDCT | 34 |
| Pseudomonas | 34 |
| Regional | 34 |
| Parkinson | 34 |
| TEG | 34 |
| Care | 33 |
| Abbott | 33 |
| Alinity | 33 |
| Australia | 33 |
| Secretariat | 33 |
| France | 33 |
| Michael | 33 |
| Staphylococcus | 33 |
| UVA | 32 |
| Rule | 32 |
| N | 32 |
| Genome | 32 |
| Efficacy | 32 |
| DOI | 32 |
| CD4 | 32 |
| Biologics | 32 |
| Asia | 32 |
| ADC | 32 |
| AB | 32 |
| fi | 32 |
| BPA | 31 |
| NF1 | 31 |
| BLA | 31 |
| Director | 31 |
| BRAF | 31 |
| School | 31 |
| Economic | 31 |
| PRP | 31 |
| Systems | 31 |
| Hepatitis | 31 |
| General | 30 |
| 3D | 30 |
| ACR | 30 |
| Alzheimer | 30 |
| CD8 | 30 |
| Diagnostic | 30 |
| Data | 30 |
| ICU | 30 |
| LSIF | 30 |
| PBM | 30 |
| PRT | 30 |
| RCC | 30 |
| Roche | 30 |
| Technical | 30 |
| FilmArray | 29 |
| A. | 29 |
| AR | 29 |
| Biotyper | 29 |
| Brazil | 29 |
| Burkholderia | 29 |
| CD34 | 29 |
| Figure | 29 |
| hepatitis | 29 |
| James | 29 |
| President | 29 |
| Regulations | 29 |
| Risk | 29 |
| SNP | 29 |
| South | 29 |
| Vol | 29 |
| pH | 29 |
| DMSO | 28 |
| HSV | 28 |
| David | 28 |
| MRA | 28 |
| Conference | 28 |
| BacT | 28 |
| AER | 28 |
| IFN | 28 |
| vivo | 28 |
| O | 28 |
| Pathology | 28 |
| RH | 28 |
| S3 | 28 |
| SC | 28 |
| Streptomyces | 28 |
| sera | 28 |
| PCC | 28 |
| HP | 27 |
| AT | 27 |
| Clinic | 27 |
| GCP | 27 |
| Global | 27 |
| Laboratories | 27 |
| MALDI | 27 |
| MRSA | 27 |
| NICU | 27 |
| Sciences | 27 |
| T. | 27 |
| TMA | 27 |
| LDPs | 26 |
| ADAMTS13 | 26 |
| ASIR | 26 |
| BeadChip | 26 |
| Diseases | 26 |
| FDG | 26 |
| Factor | 26 |
| Guidelines | 26 |
| Hct | 26 |
| TOF | 26 |
| LRAP | 26 |
| Technology | 26 |
| Middle | 26 |
| UC | 26 |
| Therapy | 26 |
| p<0.0001 | 26 |
| SpDP | 26 |
| North | 26 |
| Nile | 26 |
| PA | 25 |
| 3CL | 25 |
| Biological | 25 |
| CJD | 25 |
| CML | 25 |
| CoVs | 25 |
| DTI | 25 |
| MedDRA | 25 |
| Novel | 25 |
| UK | 25 |
| Plan | 25 |
| QC | 25 |
| TA | 25 |
| TB | 25 |
| buffy | 25 |
| Vitek | 25 |
| Wuhan | 25 |
| Project | 25 |
| HDN | 24 |
| A1 | 24 |
| African | 24 |
| Authorization | 24 |
| Chen | 24 |
| Cooperation | 24 |
| EEC | 24 |
| Foundation | 24 |
| Executive | 24 |
| HEA | 24 |
| Infection | 24 |
| NAATs | 24 |
| ONEG | 24 |
| Step | 24 |
| VP35 | 24 |
| York | 24 |
| HPA | 24 |
| Gen | 23 |
| MP | 23 |
| LISS | 23 |
| HPV | 23 |
| HCT | 23 |
| Analysis | 23 |
| FTFI | 23 |
| Christopher | 23 |
| CRS | 23 |
| POC | 23 |
| P | 23 |
| PE | 23 |
| valsartan | 23 |
| Patients | 23 |
| Paul | 23 |
| Post | 23 |
| Probe | 23 |
| Product | 23 |
| Remdesivir | 23 |
| SNR | 23 |
| Texas | 23 |
| V | 23 |
| Parliament | 23 |
| Harmonization | 22 |
| Application | 22 |
| CFU | 22 |
| Mayo | 22 |
| Reference | 22 |
| Richard | 22 |
| Type | 22 |
| van | 22 |
| HDFN | 21 |
| AI | 21 |
| AS-3 | 21 |
| Bio | 21 |
| CTA | 21 |
| Central | 21 |
| Detection | 21 |
| EGFR | 21 |
| GM | 21 |
| Germany | 21 |
| Grifols | 21 |
| Groups | 21 |
| Babesia | 21 |
| Immunohematology | 21 |
| Respiratory | 21 |
| Impact | 21 |
| kg | 21 |
| Ultrasound | 21 |
| TNF | 21 |
| Standards | 21 |
| Scientific | 21 |
| DR | 21 |
| Oncology | 21 |
| MSBOS | 21 |
| MRE | 21 |
| Influenza | 21 |
| PLTs | 21 |
| Marilyn | 20 |
| DARA | 20 |
| John | 20 |
| HBsAg | 20 |
| ESD | 20 |
| ERCP | 20 |
| CO | 20 |
| Code | 20 |
| Canadian | 20 |
| CA | 20 |
| Access | 20 |
| ARFI | 20 |
| ARDP | 20 |
| Kell | 20 |
| Security | 20 |
| Medicinal | 20 |
| TXA | 20 |
| range | 20 |
| plt | 20 |
| X | 20 |
| Neg | 20 |
| Verigene | 20 |
| WSAQ | 20 |
| Summit | 20 |
| Singapore | 20 |
| Serologic | 20 |
| Pathogen | 20 |
| Paper | 20 |
| K. | 19 |
| Hydroxychloroquine | 19 |
| HEV | 19 |
| H | 19 |
| Creutzfeldt | 19 |
| Ministers | 19 |
| Centralized | 19 |
| Antibodies | 19 |
| ALC | 19 |
| AHG | 19 |
| 16S | 19 |
| Kingdom | 19 |
| GA | 19 |
| PHS | 19 |
| TG | 19 |
| Pacific | 19 |
| Wisconsin | 19 |
| Trima | 19 |
| Terumo | 19 |
| azithromycin | 19 |
| Susan | 19 |
| Stuart | 19 |
| Secretary | 19 |
| RhD | 19 |
| Protein | 19 |
| F. | 18 |
| Nancy | 18 |
| Mark | 18 |
| KRAS | 18 |
| IRs | 18 |
| IRL | 18 |
| High | 18 |
| Good | 18 |
| Gene | 18 |
| FD&C | 18 |
| BCR | 18 |
| Edward | 18 |
| Eastern | 18 |
| Duke | 18 |
| Concept | 18 |
| CAP | 18 |
| PDB | 18 |
| BB | 18 |
| Affairs | 18 |
| ALERT | 18 |
| Nations | 18 |
| IgE | 18 |
| PPWG | 18 |
| Smith | 18 |
| α | 18 |
| PT | 18 |
| tocilizumab | 18 |
| mTOR | 18 |
| mL | 18 |
| ivermectin | 18 |
| ZKV | 18 |
| Trials | 18 |
| Stanford | 18 |
| Spectra | 18 |
| Williams | 18 |
| Science | 18 |
| Rapid | 18 |
| Pharmaceuticals | 18 |
| San | 18 |
| Protocol | 18 |
| Procleix | 18 |
| Robert | 18 |
| SP | 18 |
| Salmonella | 18 |
| Improvement | 17 |
| Cosmetic | 17 |
| Hodgkin | 17 |
| Forum | 17 |
| FIG | 17 |
| EEA | 17 |
| Drugs | 17 |
| Draft | 17 |
| Dara | 17 |
| DC | 17 |
| ARDS | 17 |
| Corporation | 17 |
| Centre | 17 |
| CHMP | 17 |
| BS | 17 |
| BBC | 17 |
| Aβ | 17 |
| Award | 17 |
| Americans | 17 |
| ASRM | 17 |
| LDP | 17 |
| Joint | 17 |
| CNR | 17 |
| LIS | 17 |
| Regulation | 17 |
| Lee | 17 |
| tularensis | 17 |
| YFV | 17 |
| TRANSFUSION | 17 |
| TMPRSS2 | 17 |
| Sysmex | 17 |
| Sanger | 17 |
| SSDE | 17 |
| Royal | 17 |
| T&S | 17 |
| Reduction | 17 |
| Pictorial | 17 |
| Peter | 17 |
| PRBC | 17 |
| PMS | 17 |
| Norcross | 17 |
| NEO | 17 |
| Mary | 17 |
| MA | 17 |
| RCF | 17 |
| GCV | 16 |
| Expert | 16 |
| FFPE | 16 |
| FVIII | 16 |
| Francisella | 16 |
| IVD | 16 |
| H. | 16 |
| HB | 16 |
| HSCT | 16 |
| Herman | 16 |
| ELISA | 16 |
| Enterobacteriaceae | 16 |
| Army | 16 |
| EA | 16 |
| Dec | 16 |
| Creative | 16 |
| Cincinnati | 16 |
| Caffey | 16 |
| CMNC | 16 |
| Belgium | 16 |
| BPN | 16 |
| BMSC | 16 |
| Assay | 16 |
| Jennifer | 16 |
| AMSC | 16 |
| AIS | 16 |
| Jakob | 16 |
| Inhibitors | 16 |
| Life | 16 |
| UDHQ | 16 |
| PLS | 16 |
| remdesivir | 16 |
| mL. | 16 |
| hydroxychloroquine | 16 |
| fl | 16 |
| burnetii | 16 |
| Yale | 16 |
| XT | 16 |
| WHA | 16 |
| WBD | 16 |
| W. | 16 |
| Venter | 16 |
| ritonavir | 16 |
| Treaty | 16 |
| QDS | 16 |
| Pharmacy | 16 |
| Philadelphia | 16 |
| Polymyxin | 16 |
| Process | 16 |
| Practices | 16 |
| R. | 16 |
| RVP | 16 |
| SCI | 16 |
| Stem | 16 |
| Switzerland | 16 |
| TAA | 16 |
| HTS | 15 |
| Escherichia | 15 |
| GE | 15 |
| Glide | 15 |
| HCQ | 15 |
| Indinavir | 15 |
| Heart | 15 |
| Hematopoietic | 15 |
| INR | 15 |
| INTERCEPT | 15 |
| IX | 15 |
| Duffy | 15 |
| ETO | 15 |
| CQA | 15 |
| Discovery | 15 |
| DENV | 15 |
| Cytomegalovirus | 15 |
| Common | 15 |
| Committees | 15 |
| CD38 | 15 |
| Brucella | 15 |
| BCT | 15 |
| BCCA | 15 |
| AutoDock | 15 |
| ABC | 15 |
| Labs | 15 |
| Kidd | 15 |
| Boston | 15 |
| Lan | 15 |
| T1 | 15 |
| Lassa | 15 |
| ng | 15 |
| cryoprecipitate | 15 |
| Yang | 15 |
| p<0.01 | 15 |
| Wang | 15 |
| WT | 15 |
| VIII | 15 |
| Tregs | 15 |
| Transplant | 15 |
| TT | 15 |
| TC | 15 |
| Y. | 15 |
| Sandra | 15 |
| Maria | 15 |
| RFLP | 15 |
| MNC | 15 |
| MPR | 15 |
| Manufacturing | 15 |
| Manual | 15 |
| Medicare | 15 |
| Meeting | 15 |
| Netherlands | 15 |
| ORP | 15 |
| Pharmacopoeia | 15 |
| EDTA | 14 |
| Force | 14 |
| ET | 14 |
| Education | 14 |
| Electronic | 14 |
| Epidemiology | 14 |
| Ethics | 14 |
| FDAAA | 14 |
| FY | 14 |
| IOM | 14 |
| G207 | 14 |
| Gel | 14 |
| Gulf | 14 |
| HIE | 14 |
| HSA | 14 |
| Innovation | 14 |
| Jason | 14 |
| Jka | 14 |
| Cobas | 14 |
| Content | 14 |
| Affymetrix | 14 |
| Class | 14 |
| Candida | 14 |
| ABSTRACT | 14 |
| ADA | 14 |
| AEs | 14 |
| ANOVA | 14 |
| Abl | 14 |
| Academy | 14 |
| Klebsiella | 14 |
| Alexander | 14 |
| Andrew | 14 |
| Angela | 14 |
| Authorities | 14 |
| Automated | 14 |
| BK | 14 |
| BacTx | 14 |
| Barbara | 14 |
| Business | 14 |
| COBE | 14 |
| Joseph | 14 |
| Haemonetics | 14 |
| Korea | 14 |
| Reporting | 14 |
| SD | 14 |
| SWI | 14 |
| Saudi | 14 |
| Seattle | 14 |
| Spectrum | 14 |
| TL | 14 |
| TRALI | 14 |
| Transmission | 14 |
| UN | 14 |
| USPSC | 14 |
| WBF | 14 |
| antigen | 14 |
| cruzi | 14 |
| darunavir | 14 |
| lopinavir | 14 |
| mAs | 14 |
| LC | 14 |
| n52 | 14 |
| simplex | 14 |
| SAGM | 14 |
| meta | 14 |
| Recognition | 14 |
| Neiman | 14 |
| RBD | 14 |
| LR | 14 |
| Laura | 14 |
| MMR | 14 |
| Marketing | 14 |
| Model | 14 |
| Mpro | 14 |
| NTZ | 14 |
| LPS | 14 |
| ODP | 14 |
| PIC | 14 |
| PRA | 14 |
| Pan | 14 |
| Panel | 14 |
| Pittsburgh | 14 |
| OR | 14 |
| RA | 14 |
| HPA-1a | 13 |
| Division | 13 |
| Down | 13 |
| EUL | 13 |
| EWG | 13 |
| Gamma | 13 |
| Geneva | 13 |
| Goals | 13 |
| IDSA | 13 |
| HSC | 13 |
| Harvey | 13 |
| IDM | 13 |
| IL | 13 |
| Iceland | 13 |
| Identification | 13 |
| Industry | 13 |
| Diagnosis | 13 |
| Int | 13 |
| Diego | 13 |
| Aotus | 13 |
| Crohn | 13 |
| Amendments | 13 |
| Kimberly | 13 |
| ABL1 | 13 |
| AVT | 13 |
| Advanced | 13 |
| Ag | 13 |
| Allergy | 13 |
| Alliance | 13 |
| Americas | 13 |
| Compounding | 13 |
| Amicus | 13 |
| Brussels | 13 |
| C11 | 13 |
| CE | 13 |
| CPT | 13 |
| Cerus | 13 |
| City | 13 |
| Karen | 13 |
| Commons | 13 |
| LA | 13 |
| RR | 13 |
| serologic | 13 |
| Rh(- | 13 |
| SDP | 13 |
| SRC | 13 |
| Scott | 13 |
| Taiwan | 13 |
| Test | 13 |
| Therapeutic | 13 |
| Trade | 13 |
| USDA | 13 |
| VRE | 13 |
| Virginia | 13 |
| Yersinia | 13 |
| ZPP | 13 |
| herpes | 13 |
| pro | 13 |
| Lab | 13 |
| Republic | 13 |
| Tyson | 13 |
| Platelets | 13 |
| NM | 13 |
| M2 | 13 |
| Platelet | 13 |
| MNS | 13 |
| MRS | 13 |
| Massachusetts | 13 |
| Mirasol | 13 |
| NIP | 13 |
| NK | 13 |
| Michigan | 13 |
| Norway | 13 |
| OTII | 13 |
| POCT | 13 |
| PVT | 13 |
| Pandemic | 13 |
| NRAs | 13 |
| Part | 13 |
| Philips | 13 |
| Erytra | 12 |
| Findings | 12 |
| Gastroenterology | 12 |
| Fy | 12 |
| Framingham | 12 |
| FC | 12 |
| FP | 12 |
| FDP | 12 |
| Exchange | 12 |
| HH | 12 |
| Genomics | 12 |
| Institutes | 12 |
| HHS | 12 |
| HMA | 12 |
| Hemolysis | 12 |
| IWG | 12 |
| Implementation | 12 |
| Inactivation | 12 |
| Inc | 12 |
| Initiative | 12 |
| Inventory | 12 |
| Jan | 12 |
| Document | 12 |
| Dose | 12 |
| Arabia | 12 |
| DEHP | 12 |
| BM | 12 |
| AML | 12 |
| Abstract | 12 |
| Alyx | 12 |
| Antibody | 12 |
| Approach | 12 |
| LF | 12 |
| Arnold | 12 |
| Assembly | 12 |
| Authority | 12 |
| BD | 12 |
| BSs | 12 |
| Consortium | 12 |
| Bruker | 12 |
| CBC | 12 |
| CMs | 12 |
| CRE | 12 |
| CS | 12 |
| Chagas | 12 |
| Chair | 12 |
| Charles | 12 |
| Chicago | 12 |
| Combination | 12 |
| Jo | 12 |
| IgA | 12 |
| List | 12 |
| Survey | 12 |
| SS | 12 |
| SSP | 12 |
| Sick | 12 |
| Single | 12 |
| Sofosbuvir | 12 |
| Southern | 12 |
| St. | 12 |
| Storage | 12 |
| Strategy | 12 |
| Summary | 12 |
| Tamiflu | 12 |
| S2 | 12 |
| Task | 12 |
| Teresa | 12 |
| UCB | 12 |
| VI | 12 |
| VIRTUO | 12 |
| corpus | 12 |
| helicase | 12 |
| imaging | 12 |
| monocyte | 12 |
| Louis | 12 |
| SA | 12 |
| TFLV | 12 |
| S1 | 12 |
| PC | 12 |
| MAA | 12 |
| Resources | 12 |
| ME | 12 |
| MSI | 12 |
| Merck | 12 |
| NJ | 12 |
| NMDP | 12 |
| ORTHO | 12 |
| PAHO | 12 |
| PBSC | 12 |
| Non | 12 |
| RRBC | 12 |
| PSS | 12 |
| Patricia | 12 |
| Pediatrics | 12 |
| Pennsylvania | 12 |
| Policy | 12 |
| Prodesse | 12 |
| Registry | 12 |
| RRV | 12 |
| Recommendations | 12 |
| Region | 12 |
| French | 11 |
| Declaration | 11 |
| Georgia | 11 |
| First | 11 |
| HTA | 11 |
| Fodor | 11 |
| EBV | 11 |
| FSIS | 11 |
| Epstein | 11 |
| Effectiveness | 11 |
| Defense | 11 |
| I. | 11 |
| Head | 11 |
| LLOQ | 11 |
| ILD | 11 |
| IVF | 11 |
| Imatinib | 11 |
| Immunization | 11 |
| Indiana | 11 |
| Italy | 11 |
| Jessica | 11 |
| Katz | 11 |
| Kelly | 11 |
| King | 11 |
| Law | 11 |
| Level | 11 |
| DMT | 11 |
| Decentralized | 11 |
| ACCSQ | 11 |
| DIIH | 11 |
| Communication | 11 |
| A2 | 11 |
| AA | 11 |
| AASLD | 11 |
| AE | 11 |
| AIHA | 11 |
| AT1RAb | 11 |
| AUC | 11 |
| Academic | 11 |
| Adam | 11 |
| Al | 11 |
| Amplicor | 11 |
| Angiography | 11 |
| Antigen | 11 |
| Arbidol | 11 |
| BIS | 11 |
| BTA | 11 |
| Lisa | 11 |
| Barr | 11 |
| British | 11 |
| Bryant | 11 |
| C3 | 11 |
| Campylobacter | 11 |
| Chloroquine | 11 |
| Cleveland | 11 |
| Collection | 11 |
| Liechtenstein | 11 |
| Baricitinib | 11 |
| MRCP | 11 |
| Willebrand | 11 |
| TP | 11 |
| TaqMan | 11 |
| Tenofovir | 11 |
| Therapeutics | 11 |
| Thomas | 11 |
| Tipranavir | 11 |
| UCSF | 11 |
| V. | 11 |
| VAERS | 11 |
| VALID | 11 |
| VCUG | 11 |
| Viral | 11 |
| William | 11 |
| TGF | 11 |
| clomiphene | 11 |
| d35 | 11 |
| dL | 11 |
| dL. | 11 |
| hgb | 11 |
| lg | 11 |
| losartan | 11 |
| mRNA | 11 |
| min | 11 |
| omalizumab | 11 |
| trans | 11 |
| Malaria | 11 |
| TMS | 11 |
| ven | 11 |
| TAH | 11 |
| RHD*DIIIa | 11 |
| Supplementary | 11 |
| Monitoring | 11 |
| Multi | 11 |
| Nicole | 11 |
| OIE | 11 |
| PAS-3 | 11 |
| PMDA | 11 |
| Pak | 11 |
| Patel | 11 |
| Plasmodium | 11 |
| Q&A | 11 |
| RHCE*ce | 11 |
| Med | 11 |
| RHSC | 11 |
| Series | 11 |
| Rad | 11 |
| Standard | 11 |
| Solutions | 11 |
| Singh | 11 |
| Supplement | 11 |
| Section | 11 |
| SNPs | 11 |
| Register | 11 |
| Raritan | 11 |
| Sanquin | 11 |
| Government | 10 |
| IFD | 10 |
| IFA | 10 |
| HCID | 10 |
| Grazoprevir | 10 |
| Genotyping | 10 |
| GmbH | 10 |
| Genetics | 10 |
| GLP | 10 |
| INN | 10 |
| Fresenius | 10 |
| G. | 10 |
| KO | 10 |
| ITP | 10 |
| ITPA | 10 |
| Island | 10 |
| Ivermectin | 10 |
| KCBB | 10 |
| Kabi | 10 |
| LDH | 10 |
| LI | 10 |
| LM | 10 |
| Li | 10 |
| Likert | 10 |
| Epic | 10 |
| MAYV | 10 |
| FAERS | 10 |
| CHM | 10 |
| ECG | 10 |
| Doppler | 10 |
| Mexico | 10 |
| 503B | 10 |
| ADHD | 10 |
| Acinetobacter | 10 |
| Agreement | 10 |
| Amotosalen | 10 |
| Anne | 10 |
| Antiviral | 10 |
| Approved | 10 |
| BMI | 10 |
| Biomedical | 10 |
| Biotechnology | 10 |
| Brian | 10 |
| CHIKV | 10 |
| CMET | 10 |
| CQ | 10 |
| CRYO | 10 |
| CV | 10 |
| Cardiac | 10 |
| CoV2 | 10 |
| Cohen | 10 |
| Collins | 10 |
| Columbia | 10 |
| Coronaviruses | 10 |
| DEHT | 10 |
| Massive | 10 |
| Johnson | 10 |
| Millennium | 10 |
| aPRP | 10 |
| Spain | 10 |
| Streptococcus | 10 |
| Supply | 10 |
| Supreme | 10 |
| Time | 10 |
| Trial | 10 |
| Van | 10 |
| Vel | 10 |
| Whitney | 10 |
| Wilcoxon | 10 |
| Xpert | 10 |
| Zealand | 10 |
| anakinra | 10 |
| Shigella | 10 |
| b- | 10 |
| biothreat | 10 |
| coat | 10 |
| kb | 10 |
| mallei | 10 |
| mm | 10 |
| mm2 | 10 |
| nan | 10 |
| siRNA | 10 |
| tetracycline | 10 |
| Modernization | 10 |
| toremifene | 10 |
| Solution | 10 |
| c.1154 | 10 |
| SVR | 10 |
| PAS | 10 |
| NANBH | 10 |
| SDH | 10 |
| Mur | 10 |
| NCBI | 10 |
| NDMA | 10 |
| Nature | 10 |
| Nurses | 10 |
| OLT | 10 |
| Optia | 10 |
| Organ | 10 |
| Ornipressin | 10 |
| Nipah | 10 |
| PLEX | 10 |
| RCT | 10 |
| Response | 10 |
| Rochester | 10 |
| PTS | 10 |
| Raltegravir | 10 |
| Radiation | 10 |
| RQS | 10 |
| Protease | 10 |
| Prequalification | 10 |
| Pharmacovigilance | 10 |
| Perlegen | 10 |
| Favipiravir | 9 |
| ERS | 9 |
| Event | 9 |
| GSH | 9 |
| Eric | 9 |
| Galileo | 9 |
| Enterococcus | 9 |
| Elizabeth | 9 |
| Direct | 9 |
| ER | 9 |
| EFTA | 9 |
| Disulfiram | 9 |
| Devices | 9 |
| Decision | 9 |
| Genomic | 9 |
| Davis | 9 |
| Database | 9 |
| Genetic | 9 |
| IQR | 9 |
| H3 | 9 |
| ISBT | 9 |
| Daniel | 9 |
| Kim | 9 |
| Kentucky | 9 |
| Jkb | 9 |
| Jeffrey | 9 |
| Janet | 9 |
| Ibrahim | 9 |
| IMMUCOR | 9 |
| HCC | 9 |
| IL-2 | 9 |
| IIa | 9 |
| IC | 9 |
| IAC | 9 |
| Hib | 9 |
| HIPAA | 9 |
| HGP | 9 |
| Darunavir | 9 |
| Appendix | 9 |
| DMSA | 9 |
| DE | 9 |
| Banks | 9 |
| Bacillus | 9 |
| BMT | 9 |
| BEN | 9 |
| Area | 9 |
| Anton | 9 |
| Annual | 9 |
| Andrea | 9 |
| AnWj | 9 |
| Agencies | 9 |
| Action | 9 |
| Accel | 9 |
| ASL | 9 |
| ADP | 9 |
| ACD | 9 |
| 8) | 9 |
| Long | 9 |
| Bill | 9 |
| Bone | 9 |
| Bordetella | 9 |
| Cepheid | 9 |
| Cryoprecipitate | 9 |
| Covid-19 | 9 |
| Connecticut | 9 |
| Congo | 9 |
| CompoTrace | 9 |
| Colistin | 9 |
| Classification | 9 |
| Cellular | 9 |
| Brain | 9 |
| Cells | 9 |
| Carolina | 9 |
| CVS | 9 |
| CD47 | 9 |
| CCR5 | 9 |
| C3d | 9 |
| Broad | 9 |
| Liu | 9 |
| RECIST | 9 |
| Low | 9 |
| TCPC | 9 |
| Tuna | 9 |
| Trauma | 9 |
| Transatlantic | 9 |
| Tissue | 9 |
| Tables | 9 |
| TGA | 9 |
| TFV | 9 |
| Sumit | 9 |
| Uganda | 9 |
| Structure | 9 |
| Strategic | 9 |
| Southeast | 9 |
| Siemens | 9 |
| Sickle | 9 |
| Screening | 9 |
| SOS | 9 |
| Tunisia | 9 |
| Universal | 9 |
| SCID | 9 |
| administration | 9 |
| Lu | 9 |
| uL | 9 |
| st | 9 |
| nivolumab | 9 |
| mOva | 9 |
| lebrikizumab | 9 |
| https | 9 |
| Zhang | 9 |
| V600 | 9 |
| Western | 9 |
| War | 9 |
| WI | 9 |
| WBMRI | 9 |
| W | 9 |
| Vero | 9 |
| VA | 9 |
| SFU | 9 |
| VFC | 9 |
| Rico | 9 |
| Medicaid | 9 |
| Overview | 9 |
| OTI | 9 |
| OSA | 9 |
| OBI | 9 |
| NBSZ | 9 |
| Microbiology | 9 |
| Mediterranean | 9 |
| Mann | 9 |
| PMN | 9 |
| MRP | 9 |
| MIFU | 9 |
| MDS | 9 |
| MDR | 9 |
| MDA | 9 |
| Results | 9 |
| MBBS | 9 |
| PBS | 9 |
| Matrix | 9 |
| Package | 9 |
| PreciseType | 9 |
| Related | 9 |
| Pathologists | 9 |
| RSNA | 9 |
| RFID | 9 |
| RDV | 9 |
| Resource | 9 |
| Puerto | 9 |
| Protection | 9 |
| R2 | 9 |
| Performance | 9 |
| Plas | 9 |
| Pharmacopeia | 9 |
| Pharmacists | 9 |
| Pharma | 9 |
| Ph | 9 |
| Population | 9 |
| House | 8 |
| Gupta | 8 |
| GvHD | 8 |
| HCI | 8 |
| HES | 8 |
| HTLA | 8 |
| HPA-5a | 8 |
| Hr | 8 |
| HbA1c | 8 |
| Hospitals | 8 |
| Gilead | 8 |
| FTE | 8 |
| GYPA | 8 |
| GERD | 8 |
| GC | 8 |
| Free | 8 |
| Florida | 8 |
| Final | 8 |
| FRCBS | 8 |
| FDASIA | 8 |
| FBC | 8 |
| Immunoglobulin | 8 |
| Excel | 8 |
| IHR | 8 |
| Log | 8 |
| Incyte | 8 |
| Index | 8 |
| En | 8 |
| MFI | 8 |
| MDGs | 8 |
| Lx | 8 |
| Lung | 8 |
| Lopinavir | 8 |
| Lin | 8 |
| License | 8 |
| LDTs | 8 |
| LCO | 8 |
| Kuwait | 8 |
| Kp | 8 |
| Kinase | 8 |
| Journal | 8 |
| Jane | 8 |
| Jacob | 8 |
| JW | 8 |
| Israel | 8 |
| Iron | 8 |
| Inspection | 8 |
| Injury | 8 |
| Establishment | 8 |
| Anna | 8 |
| Egypt | 8 |
| Applications | 8 |
| CXCR5 | 8 |
| CWP | 8 |
| CGMP | 8 |
| CDH | 8 |
| CCTA | 8 |
| CB | 8 |
| Breakthrough | 8 |
| Basic | 8 |
| B1 | 8 |
| Assays | 8 |
| Anderson | 8 |
| Effect | 8 |
| Alberta | 8 |
| Alabama | 8 |
| Acute | 8 |
| Acker | 8 |
| AS-1 | 8 |
| ARB | 8 |
| AIDR | 8 |
| AHC | 8 |
| 5D | 8 |
| MM | 8 |
| CYP2D6 | 8 |
| CYP3A4 | 8 |
| Caribbean | 8 |
| Chest | 8 |
| Ed | 8 |
| EKG | 8 |
| EHR | 8 |
| EGA | 8 |
| ECP | 8 |
| Donald | 8 |
| Dolutegravir | 8 |
| Dolly | 8 |
| Disinfection | 8 |
| DMD | 8 |
| DHQ | 8 |
| DFA | 8 |
| DBF | 8 |
| Current | 8 |
| Coxiella | 8 |
| Court | 8 |
| Conclusion | 8 |
| Components | 8 |
| Christine | 8 |
| Chiari | 8 |
| Chi | 8 |
| MLT | 8 |
| Requirements | 8 |
| MMA | 8 |
| Tesla | 8 |
| WAN | 8 |
| WAIHA | 8 |
| Verax | 8 |
| Vascular | 8 |
| Validation | 8 |
| V600E | 8 |
| USP | 8 |
| U.N. | 8 |
| Trypanosoma | 8 |
| Tortuosity | 8 |
| Technologies | 8 |
| SCH | 8 |
| TSS | 8 |
| TNC | 8 |
| TAT | 8 |
| Syphilis | 8 |
| Studio | 8 |
| Spearman | 8 |
| Simvastatin | 8 |
| Sieving | 8 |
| Schlauder | 8 |
| Sarah | 8 |
| WBIT | 8 |
| Wilms | 8 |
| XMRV | 8 |
| Yu | 8 |
| MT | 8 |
| β | 8 |
| § | 8 |
| von | 8 |
| telmisartan | 8 |
| speci | 8 |
| rRNA | 8 |
| parainfluenza | 8 |
| osteoid | 8 |
| immunoassays | 8 |
| glycophorin | 8 |
| favipiravir | 8 |
| ema | 8 |
| dif | 8 |
| cytomegalovirus | 8 |
| ct | 8 |
| candesartan | 8 |
| bevacizumab | 8 |
| anterior | 8 |
| amodiaquine | 8 |
| alloanti | 8 |
| SSRBCs | 8 |
| Woodcock | 8 |
| Rio | 8 |
| NBM-200 | 8 |
| P.L. | 8 |
| Oocyte | 8 |
| Ohio | 8 |
| OPA | 8 |
| OB | 8 |
| Nov | 8 |
| Nitazoxanide | 8 |
| Nelfinavir | 8 |
| Neil | 8 |
| Neck | 8 |
| NAC | 8 |
| PDGF | 8 |
| Mutual | 8 |
| Monica | 8 |
| Minnesota | 8 |
| Minitab | 8 |
| Miller | 8 |
| Microsoft | 8 |
| Melanie | 8 |
| Magnetic | 8 |
| MTS | 8 |
| Rimantadine | 8 |
| PBMC | 8 |
| NCTX | 8 |
| RAC | 8 |
| Professor | 8 |
| Resonance | 8 |
| PHT | 8 |
| β1b | 8 |
| Reproductive | 8 |
| Regulators | 8 |
| Rare | 8 |
| ROI | 8 |
| Quantitative | 8 |
| QUS | 8 |
| Q | 8 |
| PubMed | 8 |
| Preclinical | 8 |
| Pre | 8 |
| PharmGKB | 8 |
| Perdue | 8 |
| Patent | 8 |
| Party | 8 |
| PVAN | 8 |
| PRISM | 8 |
| PREA | 8 |
| PK | 8 |
| Equipment | 7 |
| Format | 7 |
| Ergotamine | 7 |
| Essay | 7 |
| FX | 7 |
| Fisher | 7 |
| DPD | 7 |
| Fragile | 7 |
| Francisco | 7 |
| Frozen | 7 |
| England | 7 |
| G6PD | 7 |
| Entry | 7 |
| DSF | 7 |
| Emory | 7 |
| EP | 7 |
| EDQM | 7 |
| EB | 7 |
| EAC | 7 |
| Donors | 7 |
| Discussion | 7 |
| Directives | 7 |
| Dependent | 7 |
| DXT | 7 |
| DRA | 7 |
| GBGT1 | 7 |
| GAVI | 7 |
| Interventional | 7 |
| GVHD | 7 |
| IAS | 7 |
| DBC | 7 |
| Japanese | 7 |
| Investigational | 7 |
| Integrated | 7 |
| Impl | 7 |
| IgG. | 7 |
| ITT | 7 |
| ITC | 7 |
| IQCP | 7 |
| IFPMA | 7 |
| IBD | 7 |
| Hemocentro | 7 |
| Galidesivir | 7 |
| Hematology | 7 |
| Heather | 7 |
| Haven | 7 |
| HS | 7 |
| HM | 7 |
| HGS | 7 |
| HCoVs | 7 |
| H5N1 | 7 |
| Gross | 7 |
| Gregg | 7 |
| Goske | 7 |
| DG | 7 |
| ADAM | 7 |
| D-42 | 7 |
| Alert | 7 |
| BioFire | 7 |
| BioClone | 7 |
| Beth | 7 |
| Benjamin | 7 |
| BST | 7 |
| BSG | 7 |
| BRCA1 | 7 |
| Authorisation | 7 |
| Associates | 7 |
| Approval | 7 |
| Antimicrobial | 7 |
| Accreditation | 7 |
| Bioshield | 7 |
| AS | 7 |
| ARC | 7 |
| AMTD | 7 |
| AMR | 7 |
| ALARA | 7 |
| AFB | 7 |
| Jiangsu | 7 |
| ACE | 7 |
| ABSC | 7 |
| AAV | 7 |
| -9.3 | 7 |
| Biomet | 7 |
| Biosystems | 7 |
| D-35 | 7 |
| Cardiovascular | 7 |
| Critical | 7 |
| Cox | 7 |
| Coulter | 7 |
| Convalescent | 7 |
| Consumer | 7 |
| CoV. | 7 |
| Co. | 7 |
| Clinton | 7 |
| Chronic | 7 |
| Chlamydia | 7 |
| Characteristics | 7 |
| CTX | 7 |
| Birmingham | 7 |
| CTPA | 7 |
| CR | 7 |
| CPOE | 7 |
| CHD | 7 |
| CD | 7 |
| CC | 7 |
| CBU | 7 |
| C1 | 7 |
| Bulks | 7 |
| Brown | 7 |
| Braintree | 7 |
| Jeremy | 7 |
| Etravirine | 7 |
| Joan | 7 |
| Stubbs | 7 |
| appendix | 7 |
| Zimmer | 7 |
| Wei | 7 |
| Weak | 7 |
| Veterinary | 7 |
| Veterans | 7 |
| Valley | 7 |
| VVR | 7 |
| VLP | 7 |
| VEGF | 7 |
| UT | 7 |
| USC | 7 |
| Treponema | 7 |
| Treg | 7 |
| Training | 7 |
| Toronto | 7 |
| Thomson | 7 |
| Thailand | 7 |
| Tertiary | 7 |
| Term | 7 |
| Tennessee | 7 |
| Taylor | 7 |
| Tab | 7 |
| TX | 7 |
| TTD | 7 |
| baicalin | 7 |
| callosum | 7 |
| cetuximab | 7 |
| n55 | 7 |
| Jones | 7 |
| −6 | 7 |
| κB | 7 |
| À | 7 |
| ® | 7 |
| tx | 7 |
| tacrolimus | 7 |
| sxs | 7 |
| sec | 7 |
| novo | 7 |
| nd | 7 |
| n51 | 7 |
| chloroquine | 7 |
| metformin | 7 |
| mass | 7 |
| mA | 7 |
| hiPS | 7 |
| gyrus | 7 |
| edu | 7 |
| ebec | 7 |
| der | 7 |
| daratumumab | 7 |
| d. | 7 |
| committee | 7 |
| Support | 7 |
| maximus | 7 |
| Staff | 7 |
| Penicillium | 7 |
| Panther | 7 |
| Pamela | 7 |
| PPE | 7 |
| PL | 7 |
| PGD | 7 |
| PACS | 7 |
| Open | 7 |
| Neonatal | 7 |
| Nanosphere | 7 |
| NF | 7 |
| Midwest | 7 |
| Method | 7 |
| Memorial | 7 |
| Max | 7 |
| Marburg | 7 |
| MMIHS | 7 |
| MMIH | 7 |
| Lypressin | 7 |
| Listeria | 7 |
| Liquid | 7 |
| Licensure | 7 |
| Le | 7 |
| Labor | 7 |
| St | 7 |
| LDT | 7 |
| Paradowski | 7 |
| MCF | 7 |
| Pf | 7 |
| Ritonavir | 7 |
| Spaulding | 7 |
| Poisson | 7 |
| Spring | 7 |
| Software | 7 |
| Sigma | 7 |
| Seth | 7 |
| Sequencing | 7 |
| Sang | 7 |
| SR | 7 |
| SLCO1B1 | 7 |
| SCV | 7 |
| Russia | 7 |
| Serratia | 7 |
| RhIG | 7 |
| Quebec | 7 |
| ProFlu-1 | 7 |
| QT | 7 |
| Polymerase | 7 |
| Qu | 7 |
| RHD*weak | 7 |
| Registration | 7 |
| Release | 7 |
| Preparedness | 7 |
| Gammaclone | 6 |
| GYPB | 6 |
| HDT | 6 |
| Ganciclovir | 6 |
| Gates | 6 |
| Gelsinger | 6 |
| Guided | 6 |
| Guinea | 6 |
| H1 | 6 |
| HIV-2 | 6 |
| HGPPS | 6 |
| Han | 6 |
| HLH | 6 |
| HLL | 6 |
| HPA-5b | 6 |
| HQ | 6 |
| Harris | 6 |
| GP | 6 |
| HVS | 6 |
| GSV | 6 |
| Facilities | 6 |
| GMH | 6 |
| FORS1 | 6 |
| Epub | 6 |
| Ethiopia | 6 |
| Hervey | 6 |
| EudraLex | 6 |
| Examorelin | 6 |
| FA | 6 |
| FACSVia | 6 |
| FBP | 6 |
| FT | 6 |
| G5 | 6 |
| Fast | 6 |
| Fer | 6 |
| Fibrinogen | 6 |
| Forssman | 6 |
| Francis | 6 |
| Frush | 6 |
| Fund | 6 |
| Future | 6 |
| Hemorrhage | 6 |
| Internal | 6 |
| Hg | 6 |
| Johns | 6 |
| Insurance | 6 |
| Intravenous | 6 |
| Investment | 6 |
| Issues | 6 |
| JS | 6 |
| Jay | 6 |
| Jean | 6 |
| Jesse | 6 |
| Jonathan | 6 |
| Inhibitor | 6 |
| José | 6 |
| Judith | 6 |
| Kadom | 6 |
| LAMP | 6 |
| LAN | 6 |
| LPV | 6 |
| Emerging | 6 |
| Labeling | 6 |
| Institutional | 6 |
| Indications | 6 |
| Hill | 6 |
| IL-1 | 6 |
| Hollie | 6 |
| Hong | 6 |
| Hopkins | 6 |
| Host | 6 |
| Huntington | 6 |
| IA | 6 |
| IC95 | 6 |
| ICH5 | 6 |
| IMP | 6 |
| Improved | 6 |
| IP | 6 |
| IRF6 | 6 |
| ISO | 6 |
| ISR | 6 |
| Immune | 6 |
| Immunoassay | 6 |
| Immunodeficiency | 6 |
| Immunology | 6 |
| Epelman | 6 |
| Bisset | 6 |
| ESTRI | 6 |
| Based | 6 |
| Atlantic | 6 |
| Availability | 6 |
| BBID | 6 |
| BCPTR | 6 |
| BL | 6 |
| BSTF | 6 |
| BT | 6 |
| Bakker | 6 |
| BloodTrack | 6 |
| Antibiotics | 6 |
| Bogor | 6 |
| Bonfils | 6 |
| CBF | 6 |
| CCR7 | 6 |
| CD3 | 6 |
| CD341 | 6 |
| CD36-n | 6 |
| CDER | 6 |
| Arthur | 6 |
| Anthony | 6 |
| ES | 6 |
| ASCO | 6 |
| Leukocyte | 6 |
| 7)-D | 6 |
| ABCB1 | 6 |
| ABID | 6 |
| ABL | 6 |
| ABR | 6 |
| ACMG | 6 |
| AMPK | 6 |
| Abdullah | 6 |
| Ang | 6 |
| Ad | 6 |
| Adenovirus | 6 |
| Aedes | 6 |
| Agricultural | 6 |
| Agriculture | 6 |
| Ali | 6 |
| Amy | 6 |
| Analytics | 6 |
| CIBMTR | 6 |
| COVID | 6 |
| CPAP | 6 |
| Docking | 6 |
| DHHS | 6 |
| DM | 6 |
| DRNC | 6 |
| Dasabuvir | 6 |
| Datalink | 6 |
| Debra | 6 |
| Dengue | 6 |
| Dept | 6 |
| Doxycycline | 6 |
| Campaign | 6 |
| Dr | 6 |
| DrugBank | 6 |
| E6 | 6 |
| ECHO | 6 |
| ECRI | 6 |
| EIA | 6 |
| ELU | 6 |
| EPA | 6 |
| DEC | 6 |
| Cyclosporin | 6 |
| CsA | 6 |
| Criteria | 6 |
| Casopitant | 6 |
| Cat | 6 |
| Chain | 6 |
| Chandra | 6 |
| Chap | 6 |
| Chemical | 6 |
| Chemistry | 6 |
| Chikungunya | 6 |
| Collaborative | 6 |
| Colorado | 6 |
| Company | 6 |
| Compliance | 6 |
| CompoMat | 6 |
| Comprehensive | 6 |
| Congenital | 6 |
| Cord | 6 |
| County | 6 |
| Leaders | 6 |
| RBS | 6 |
| LibDock | 6 |
| VWF | 6 |
| Tx | 6 |
| U. | 6 |
| Unit | 6 |
| VEPTR | 6 |
| VHP | 6 |
| VL | 6 |
| VRBPAC | 6 |
| VS | 6 |
| Valganciclovir | 6 |
| Tuberculosis | 6 |
| Value | 6 |
| Vina | 6 |
| Vitro | 6 |
| Volume | 6 |
| WBEX | 6 |
| WCF | 6 |
| Whole | 6 |
| Wilson | 6 |
| Tushar | 6 |
| Trust | 6 |
| Workshop | 6 |
| TKI | 6 |
| Stramer | 6 |
| Student | 6 |
| SureSelect | 6 |
| Surgical | 6 |
| Sydney | 6 |
| T5 | 6 |
| TBSF | 6 |
| TIGR | 6 |
| TPN | 6 |
| Transplantation | 6 |
| TSD | 6 |
| Target | 6 |
| Taybi | 6 |
| Titer | 6 |
| Title | 6 |
| Tormey | 6 |
| Towbin | 6 |
| Track | 6 |
| Women | 6 |
| Wu | 6 |
| Statistical | 6 |
| rhabdomyosarcoma | 6 |
| monensin | 6 |
| n01 | 6 |
| neg | 6 |
| ortho | 6 |
| palivizumab | 6 |
| pembrolizumab | 6 |
| phthalaldehyde | 6 |
| rd | 6 |
| spinosyns | 6 |
| lks | 6 |
| supra | 6 |
| trimethoprim | 6 |
| valganciclovir | 6 |
| zoster | 6 |
| β1 | 6 |
| β19-β20 | 6 |
| Linda | 6 |
| μSv | 6 |
| mid | 6 |
| key | 6 |
| XIII | 6 |
| bullosa | 6 |
| Xu | 6 |
| Y | 6 |
| Yellow | 6 |
| author(s | 6 |
| autoAb | 6 |
| b1 | 6 |
| benralizumab | 6 |
| bp | 6 |
| cation | 6 |
| hepcidin | 6 |
| cine | 6 |
| cingulate | 6 |
| cyclophilin | 6 |
| doxycycline | 6 |
| etanercept | 6 |
| fMRI | 6 |
| gluteus | 6 |
| hemangiomas | 6 |
| Stephen | 6 |
| XM | 6 |
| Spike | 6 |
| NEG | 6 |
| Ministerial | 6 |
| Mo | 6 |
| Mohit | 6 |
| Mycoplasma | 6 |
| N. | 6 |
| NATs | 6 |
| NCCN | 6 |
| NEC | 6 |
| NIAID | 6 |
| Miami | 6 |
| NS | 6 |
| NSAID | 6 |
| Nadja | 6 |
| Nanoparticle | 6 |
| Nbl | 6 |
| Neisseria | 6 |
| Newell | 6 |
| Nguyen | 6 |
| Microbial | 6 |
| Meta | 6 |
| Northwestern | 6 |
| MRV | 6 |
| Liver | 6 |
| Luxembourg | 6 |
| Solidarity | 6 |
| Lynch | 6 |
| MAIPA | 6 |
| MCS1 | 6 |
| MMS | 6 |
| MRSI | 6 |
| Mab | 6 |
| Melissa | 6 |
| Maestro | 6 |
| Maheshwari | 6 |
| Malaysia | 6 |
| Margaret | 6 |
| Marie | 6 |
| Martin | 6 |
| MedWatch | 6 |
| Medication | 6 |
| Nilotinib | 6 |
| Michelle | 6 |
| O'Neill | 6 |
| RCDAD | 6 |
| RHCE*ce(733 | 6 |
| ROTEM | 6 |
| Radiologic | 6 |
| Radiologist | 6 |
| Readiness | 6 |
| Reagent | 6 |
| Records | 6 |
| Representative | 6 |
| Rick | 6 |
| S6 | 6 |
| SAM | 6 |
| Santos | 6 |
| Sci | 6 |
| Screens | 6 |
| Segall | 6 |
| OC43 | 6 |
| Senate | 6 |
| Shiga | 6 |
| Shah | 6 |
| RGT | 6 |
| Rebecca | 6 |
| PKD | 6 |
| PV | 6 |
| Oklahoma | 6 |
| OPG | 6 |
| P1 | 6 |
| PF24 | 6 |
| PI | 6 |
| PMD | 6 |
| PMV | 6 |
| PS | 6 |
| Park | 6 |
| Partnership | 6 |
| Pioneer | 6 |
| Priority | 6 |
| Progenika | 6 |
| QualTex | 6 |
| Quantitation | 6 |
| Ontario | 6 |
| EudraVigilance | 5 |
| FCS | 5 |
| Excellence | 5 |
| Ex | 5 |
| Fernandez | 5 |
| Environmental | 5 |
| Enterobacter | 5 |
| English | 5 |
| FDCA | 5 |
| Enforcement | 5 |
| FDAMA | 5 |
| Factors | 5 |
| Foods | 5 |
| FHCA | 5 |
| FPV | 5 |
| FRC | 5 |
| FTC | 5 |
| Flu | 5 |
| Fee | 5 |
| Fenwal | 5 |
| Emetine | 5 |
| Energy | 5 |
| DDH | 5 |
| Emerge | 5 |
| El | 5 |
| Cryopreserved | 5 |
| Crisis | 5 |
| Frequency | 5 |
| Crystal | 5 |
| Cumming | 5 |
| Cystic | 5 |
| DLP | 5 |
| DTPA | 5 |
| Daneman | 5 |
| Daratumumab | 5 |
| Dartmouth | 5 |
| Denmark | 5 |
| Dennis | 5 |
| Directors | 5 |
| Doria | 5 |
| Dorothy | 5 |
| E1 | 5 |
| ECSPP | 5 |
| EOB | 5 |
| ESA | 5 |
| Echo | 5 |
| Form | 5 |
| Justin | 5 |
| Functional | 5 |
| Fya | 5 |
| Hologic | 5 |
| Homeland | 5 |
| IH-1000 | 5 |
| IIb | 5 |
| INT | 5 |
| INTERCEPTV | 5 |
| IVIM | 5 |
| Ian | 5 |
| Investigator | 5 |
| JACIE | 5 |
| Janeiro | 5 |
| Janus | 5 |
| Jappe | 5 |
| Juffermans | 5 |
| KBC | 5 |
| Key | 5 |
| Kpb | 5 |
| L1 | 5 |
| Lakewood | 5 |
| Country | 5 |
| Larry | 5 |
| Hoc | 5 |
| His41 | 5 |
| Hetastarch | 5 |
| HCO | 5 |
| G1 | 5 |
| GDP | 5 |
| GPB | 5 |
| Gao | 5 |
| Gd | 5 |
| Golgi | 5 |
| Gregory | 5 |
| Gülsen | 5 |
| HBc | 5 |
| HEMS | 5 |
| Herpes | 5 |
| HHT | 5 |
| HPA-1 | 5 |
| HSV-1 | 5 |
| HSV-2 | 5 |
| HUS | 5 |
| HV | 5 |
| Harmonisation | 5 |
| Hemophilia | 5 |
| Hendra | 5 |
| Cr | 5 |
| ASFA | 5 |
| Countries | 5 |
| BUC | 5 |
| Allogeneic | 5 |
| Alloimmunization | 5 |
| Amanda | 5 |
| Amsterdam | 5 |
| Angiotensin | 5 |
| Anita | 5 |
| Ann | 5 |
| Annapragada | 5 |
| Anomalies | 5 |
| Arab | 5 |
| Archives | 5 |
| Arkansas | 5 |
| Ashley | 5 |
| Asian | 5 |
| Associated | 5 |
| Associations | 5 |
| Assurance | 5 |
| Asthma | 5 |
| Atlanta | 5 |
| BBTMS | 5 |
| BCA | 5 |
| Albert | 5 |
| Ags | 5 |
| Agent | 5 |
| APs | 5 |
| LeanSequencing | 5 |
| 2001/83 | 5 |
| 28S | 5 |
| 2D | 5 |
| AC | 5 |
| ACTD | 5 |
| AHI | 5 |
| APIC | 5 |
| APP | 5 |
| ASD | 5 |
| Africans | 5 |
| AVVR | 5 |
| Aaron | 5 |
| Acad | 5 |
| Accountability | 5 |
| Activity | 5 |
| Administrative | 5 |
| Adult | 5 |
| Adv | 5 |
| Advocate | 5 |
| BKV | 5 |
| Bacteroides | 5 |
| Cost | 5 |
| Banc | 5 |
| CYP2C8 | 5 |
| Campus | 5 |
| Card | 5 |
| Cardiology | 5 |
| Carnevale | 5 |
| Caucasians | 5 |
| Celera | 5 |
| Chang | 5 |
| Chiron | 5 |
| Chung | 5 |
| Citra | 5 |
| Client | 5 |
| Clin | 5 |
| ClinicalTrials.gov | 5 |
| Coast | 5 |
| Conditional | 5 |
| Connie | 5 |
| Consensus | 5 |
| Contrast | 5 |
| Convention | 5 |
| Correlation | 5 |
| CTDIVOL | 5 |
| CRMO | 5 |
| CPMP | 5 |
| CAD | 5 |
| Beckman | 5 |
| BioBall | 5 |
| BioMérieux | 5 |
| Biofilms | 5 |
| Black | 5 |
| Bloodworks | 5 |
| Body | 5 |
| Box | 5 |
| Brenner | 5 |
| CAQ | 5 |
| CPD | 5 |
| CCI | 5 |
| CD62p | 5 |
| CD81 | 5 |
| CFTR | 5 |
| CGG | 5 |
| CIA | 5 |
| CMS | 5 |
| COG | 5 |
| CPC | 5 |
| Latin | 5 |
| coronaviruses | 5 |
| Leparc | 5 |
| Zhou | 5 |
| Unicamp | 5 |
| Urography | 5 |
| VEEV | 5 |
| VO | 5 |
| VRNAT | 5 |
| VUS | 5 |
| Vanderbilt | 5 |
| Vice | 5 |
| Voluntary | 5 |
| WVS | 5 |
| Waals | 5 |
| Walker | 5 |
| Warren | 5 |
| Wedi | 5 |
| Williamson | 5 |
| Yemen | 5 |
| Ying | 5 |
| Young | 5 |
| ZINC000003978005 | 5 |
| ZINC000052955754 | 5 |
| ZMapp | 5 |
| URD | 5 |
| UNICEF | 5 |
| UKMC | 5 |
| Sterilization | 5 |
| Simplification | 5 |
| Singleton | 5 |
| Sneeringer | 5 |
| Southwestern | 5 |
| Specific | 5 |
| Spinal | 5 |
| Sponsor | 5 |
| Status | 5 |
| Stephanie | 5 |
| Steve | 5 |
| Trichomonas | 5 |
| Surveillance | 5 |
| Synteni | 5 |
| TJM2 | 5 |
| TSC | 5 |
| TTI | 5 |
| Team | 5 |
| Teixits | 5 |
| Thermo | 5 |
| Tokyo | 5 |
| Zettler | 5 |
| adnexal | 5 |
| Sherry | 5 |
| amotosalen | 5 |
| mmol | 5 |
| ms | 5 |
| nelfinavir | 5 |
| non | 5 |
| osteoma | 5 |
| osteomas | 5 |
| p<.0001 | 5 |
| pestis | 5 |
| plateletpheresis | 5 |
| poxvirus | 5 |
| pyeloplasty | 5 |
| rDNA | 5 |
| resp | 5 |
| signi | 5 |
| transmembrane | 5 |
| txs | 5 |
| uenza | 5 |
| vCJD | 5 |
| vWF | 5 |
| wall | 5 |
| Lesions | 5 |
| mepolizumab | 5 |
| maltophilia | 5 |
| lipaemia | 5 |
| doc_id | 5 |
| aplasia | 5 |
| bili | 5 |
| board | 5 |
| bronchoscopes | 5 |
| captopril | 5 |
| carina | 5 |
| cobas | 5 |
| dermatomyositis | 5 |
| disease | 5 |
| drug | 5 |
| leucocyte | 5 |
| endoscopy | 5 |
| endosomal | 5 |
| g. | 5 |
| hyperbilirubinemia | 5 |
| hyperpolarized | 5 |
| identi | 5 |
| immunoblot | 5 |
| infliximab | 5 |
| kV | 5 |
| Silver | 5 |
| spp | 5 |
| Senior | 5 |
| PSE | 5 |
| NF-1 | 5 |
| NMOSD | 5 |
| NRA | 5 |
| Names | 5 |
| Natural | 5 |
| Nebraska | 5 |
| Neo | 5 |
| News | 5 |
| Nucleic | 5 |
| OHRP | 5 |
| Olympus | 5 |
| Operations | 5 |
| PDUFA | 5 |
| PIV-1 | 5 |
| PIV-2 | 5 |
| PIV-3 | 5 |
| POD | 5 |
| POS | 5 |
| POST | 5 |
| PPV | 5 |
| PRE | 5 |
| NECC | 5 |
| NCI | 5 |